Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease

doi:10.1016/0002-8703(93)90535-H

American Heart Journal

Volume 126, Issue 6, December 1993, Pages 1364-1372

https://doi.org/10.1016/0002-8703(93)90535-H Get rights and content

Abstract

Heart rate variability (HRV) and its circadian rhythm were evaluated in 22 patients with treated hypertension and left ventricular hypertrophy in whom coronary artery disease was excluded by stress thallium or angiography. By using 24-hour Holter monitoring, HRV and its spectral components were measured. Findings were compared with 11 age-matched normal controls. The difference between mean R-R intervals during sleep (11 pm to 7 am) and while awake (9 am to 9 pm) (73 ± 33 vs 263 ± 63 msec, p < 0.0001) and the mean 24-hour SD of the R-R intervals (55 ± 6.3 vs 93 ± 11, p < 0.0001) were lower among the hypertensive patients compared with controls. The percentage of difference between successive R-R intervals that exceeded 50 msec, a measure of parasympathetic tone, was also lower among the hypertensive patients (6.8 ± 7.1 vs 13.6 ± 8.9, p < 0.002); it increased at night and decreased during the day among the controls, and this circadian rhythm was blunted among the patients. Spectral analysis showed that power in the high-frequency range (0.15 to 0.40 Hz) was lower among the hypertensive patients during 21 of 24 hours but that the difference was statistically significant only during 9 hours (p ranging from <0.05 to 0.009). Power in the low-frequency range (0.04 to 015 Hz) was lower at night, increased in the morning, and higher during the day among controls; this circadian rhythm was absent among hypertensive patients. Among hypertensive patients free of coronary artery disease, HRV is decreased with a partial withdrawal of parasympathetic tone, and the circadian rhythm of sympathetic/parasympathetic tone is altered.

References (29)

RE Kleiger et al.
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
Am J Cardiol
(1987)
JT Bigger et al.
Components of heart rate variability measured during healing of acute myocardial infarction
Am J Cardiol
(1988)
MW Rich et al.
Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography
Am J Cardiol
(1988)
HV Huikuri et al.
Reproducibility and circadian rhythm of heart rate variability in healthy subjects
Am J Cardiol
(1990)
H Molgaard et al.
Circadian variation and influence of risk factors on heart rate variability in healthy subjects
Am J Cardiol
(1991)
HV Huikuri et al.
Circadian rhythm of heart rate variability in survivors of cardiac arrest
Am J Cardiol
(1992)
RB Devereux et al.
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings
Am J Cardiol
(1986)
RE Kleiger et al.
Stability over time of variables measuring heart rate variability in normal subjects
Am J Cardiol
(1991)
JR Cook et al.
Effect of atenolol and diltiazem on heart period variability in normal persons
J Am Coll Cardiol
(1991)
JT Bigger et al.
Stability over time of heart period variability in patients with myocardial infarction and ventricular arrhythmias
Am J Cardiol
(1992)

GJ Martin et al.

Heart rate variability and sudden death secondary to coronary artery disease during ambulatory electrocardiographic monitoring

Am J Cardiol

(1987)

G Mancia et al.

Cardiovascular regulation during sleep

J Hayano et al.

Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects

Am J Cardiol

(1991)

KJ Osterziel et al.

ACE inhibition improves vagal reactivity in patients with heart failure

Am Heart J

(1990)

Cited by (118)

Measures of sleep and cardiac functioning during sleep using a multi-sensory commercially-available wristband in adolescents
2016, Physiology and Behavior
Citation Excerpt :
Also, HR and HR variability measures fluctuate across the night under circadian and sleep-dependent influences [36]. The accurate detection of these fluctuations, particularly the measurement of heart rate variability (not supported by the current Fitbit models), may be highly informative in efforts to accurately assess variation in nighttime patterns of vagal activity, an important indication of potential health risk [37,38]. Knowing the limits and the advantages of these novel activity-trackers informs researchers and clinicians about the circumstances in which these wearables can be validly used.
To validate measures of sleep and heart rate (HR) during sleep generated by a commercially-available activity tracker against those derived from polysomnography (PSG) in healthy adolescents. Sleep data were concurrently recorded using FitbitChargeHR™ and PSG, including electrocardiography (ECG), during an overnight laboratory sleep recording in 32 healthy adolescents (15 females; age, mean ± SD: 17.3 ± 2.5 years). Sleep and HR measures were compared between FitbitChargeHR™ and PSG using paired t-tests and Bland-Altman plots. Epoch-by-epoch analysis showed that FitbitChargeHR™ had high overall accuracy (91%), high sensitivity (97%) in detecting sleep, and poor specificity (42%) in detecting wake on a min-to-min basis. On average, FitbitChargeHR™ significantly but negligibly overestimated total sleep time by 8 min and sleep efficiency by 1.8%, and underestimated wake after sleep onset by 5.6 min (p < 0.05). Within FitbitChargeHR™ epochs of sleep, the average HR was 59.3 ± 7.5 bpm, which was significantly but negligibly lower than that calculated from ECG (60.2 ± 7.6 bpm, p < 0.001), with no change in mean discrepancies throughout the night. FitbitChargeHR™ showed good agreement with PSG and ECG in measuring sleep and HR during sleep, supporting its use in assessing sleep and cardiac function in healthy adolescents. Further validation is needed to assess its reliability over prolonged periods of time in ecological settings and in clinical populations.
Determinants of cardiac vagal regulation: A cross-sectional study in a general population
2011, Autonomic Neuroscience: Basic and Clinical
Citation Excerpt :
Reduced heart rate variability is associated with an increased risk of cardiovascular morbidity and mortality in various patient populations (Kleiger et al., 1987, Bigger et al., 1993, and Tsuji et al., 1994). Impaired autonomic control of heart rate is common in coronary artery disease (Kleiger et al., 1987, Airaksinen et al., 1987, and Hayano, Sakakibara, Yamanda, Othe, Fujinami, Yokoyama, Watanabe and Takata, 1990) and hypertension (Chakko et al., 1993 and Langewitz et al., 1994), and is also associated with an increased risk of life threatening arrhythmias (Martin et al., 1987 and Huikuri et al., 1993). Impaired HRV has also been reported in diabetic patients both with and without evidence of autonomic neuropathy (Pagani et al., 1998).
Attenuated cardiac vagal regulation indicates an increased risk of cardiac events, but the reasons for this impaired regulation are not well known.
Cardiac vagal regulation was measured in 5.408 subjects (2627 men and 2781 women) who underwent short term (100 s) ECG recordings during controlled deep respiration (0.1 Hz). Under these conditions, the power in the low frequency (LF) spectral band (0.05 to 0.15 Hz) predominantly reflects cardiac vagal outflow.
There was a strong inverse relationship between LF power and age in both genders (β = − 0.033 in men and − 0.035 in women; P < 0.0005). There was a more rapid decline in women in the second and third decade in which LF power was significantly lower than in men (P = 0.004). In both genders, there was an association between impaired cardiac vagal outflow and fibrinogen level. Altogether, the factors studied explained nearly 20% of the interindividual variation of LF power.
In conclusion, in a general population, impaired cardiac vagal regulation is associated with many cardiovascular risk factors, including fibrinogen. Women have a more rapid decline of vagal regulation in the second and third decades.
Heart rate variability explored in the frequency domain: A tool to investigate the link between heart and behavior
2009, Neuroscience and Biobehavioral Reviews
The neural regulation of circulatory function is mainly effected through the interplay of the sympathetic and vagal outflows. This interaction can be explored by assessing cardiovascular rhythmicity with appropriate spectral methodologies. Spectral analysis of cardiovascular signal variability, and in particular of RR period (heart rate variability, HRV), is a widely used procedure to investigate autonomic cardiovascular control and/or target function impairment. The oscillatory pattern which characterizes the spectral profile of heart rate and arterial pressure short-term variability consists of two major components, at low (LF, 0.04–0.15 Hz) and high (HF, synchronous with respiratory rate) frequency, respectively, related to vasomotor and respiratory activity. With this procedure the state of sympathovagal balance modulating sinus node pacemaker activity can be quantified in a variety of physiological and pathophysiological conditions. Changes in sympathovagal balance can be often detected in basal conditions, however a reduced responsiveness to an excitatory stimulus is the most common feature that characterizes numerous pathophysiological states. Moreover the attenuation of an oscillatory pattern or its impaired responsiveness to a given stimulus can also reflect an altered target function and thus can furnish interesting prognostic markers. The dynamic assessment of these autonomic changes may provide crucial diagnostic, therapeutic and prognostic information, not only in relation to cardiovascular, but also non-cardiovascular disease. As linear methodologies fail to provide significant information in conditions of extremely reduced variability (e.g. strenuous exercise, heart failure) and in presence of rapid and transients changes or coactivation of the two branches of autonomic nervous system, the development of new non-linear approaches seems to provide a new perspective in investigating neural control of cardiovascular system.
Resistance exercise lowers blood pressure and improves vascular endothelial function in individuals with elevated blood pressure or stage-1 hypertension
2024, American Journal of Physiology - Heart and Circulatory Physiology
Heart Rate Variability Assessment of Land Navigation and Load Carriage Activities in Specialist Police Selection
2023, Healthcare (Switzerland)
Explanation of HRV Features for Detecting Atrial Fibrillation
2022, SN Computer Science

View all citing articles on Scopus

View full text

Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease

Abstract

Am J Cardiol

Am J Cardiol

Am J Cardiol

Am J Cardiol

Am J Cardiol

Am J Cardiol

Am J Cardiol

Am J Cardiol

J Am Coll Cardiol

Am J Cardiol

Am J Cardiol

Am J Cardiol

Am Heart J